Chinese- REPORT SUMMARY
- TABLE OF CONTENTS
-
The report details the trend, potential and market size of Intravenous (IV) Ibuprofen market, and analyzes the current situation and prospects of the market from both qualitative and quantitative aspects, which can be roughly divided into three parts.
The first part (Chapter1-7) mainly covers the qualitative analysis of Intravenous (IV) Ibuprofenmarket, defines the market attractiveness level of Intravenous (IV) Ibuprofen market through Porter's Five Forces Analysis, and summarizes the different factors in the overall environment through PEST analysis. Understand the distribution of industrial chain value in each link of industrial chain through the analysis of industrial chain structure. Thus estimate the market space of each link.
The second part (Chapter8-12), based on the segmentation of Intravenous (IV) Ibuprofen industry, describes the types of Intravenous (IV) Ibuprofen market, the applications of major players and the market size, and deeply analyzes the current situation of the global Intravenous (IV) Ibuprofen market and the development prospects and opportunities of Intravenous (IV) Ibuprofen industry.
The third part (Chapter14-15) includes the market positions of the major players and information on the market participants, which will help you gain a comprehensive understanding of the current competitive situation and potential growth opportunities in the market.
As COVID-19 continues to impact the global economy in 2022, the report also considers the short - and long-term impacts of COVID-19 on the global Intravenous (IV) Ibuprofen market in Chapter 13.
By Player:
Germin MED
Laboratorios Valmorca
Grifols
Al Nabeel International
Gloria Pharmaceuticals
Cumberland Pharmaceuticals
Alveda Pharmaceuticals
Sandor Medicaids
CSL Limited
PT Soho Industri Pharmasi
By Type:
100 mg Dose
200 mg Dose
400 mg Dose
800 mg Dose
By End-User:
Pain
Fever
Inflammation
By Geography:
-
United States
-
Europe
-
China
-
Japan
-
India
-
South Korea
TABLE OF CONTENT
1 Introduction
-
1.1 Market Definition
-
1.2 Market Segment Analysis
-
1.3 Market Size 2022
-
1.4 Intravenous (IV) Ibuprofen Market Outlook: Forecast for 2022 - 2028
-
1.5 Pricing Analysis
2 Executive Summary
3 Intravenous (IV) Ibuprofen Market Lineage Outlook
-
3.1 Parent Market Outlook
-
3.2 Related/Ancillary Market Outlook
-
3.3 Penetration & Growth Prospect Mapping, 2022
4 Market Analysis Tools: Porter's Five Forces
-
4.1 Supplier Power
-
4.2 Buyer Power
-
4.3 Substitution Threat
-
4.4 Threat of New Entrants
-
4.5 Competitive Rivalry
5 Intravenous (IV) Ibuprofen Industry Analysis - PEST (Political & Legal, Economic, Social, and Technological)
-
5.1 Political/Legal Landscape
-
5.2 Economic Landscape
-
5.3 Social Landscape
-
5.4 Technology Landscape
6 Intravenous (IV) Ibuprofen Market - Value Chain Analysis
-
6.1 Industry's Value Chain Analysis
-
6.2 Product Life Cycle
-
6.3 User Perspective Analysis
7 Region and Country-wise Intravenous (IV) Ibuprofen Market Analysis and Outlook to 2022
-
7.1 Global Intravenous (IV) Ibuprofen Consumption (2017-2022)
-
7.2 United States Intravenous (IV) Ibuprofen Consumption (2017-2022)
-
7.3 Europe Intravenous (IV) Ibuprofen Consumption (2017-2022)
-
7.4 China Intravenous (IV) Ibuprofen Consumption (2017-2022)
-
7.5 Japan Intravenous (IV) Ibuprofen Consumption (2017-2022)
-
7.6 India Intravenous (IV) Ibuprofen Consumption (2017-2022)
-
7.7 South Korea Intravenous (IV) Ibuprofen Consumption (2017-2022)
8 Region and Country-wise Intravenous (IV) Ibuprofen Market Analysis and Outlook to 2028
-
8.1 Global Intravenous (IV) Ibuprofen Consumption Forecast (2022-2028)
-
8.2 United States Intravenous (IV) Ibuprofen Consumption Forecast (2022-2028)
-
8.3 Europe Intravenous (IV) Ibuprofen Consumption Forecast (2022-2028)
-
8.4 China Intravenous (IV) Ibuprofen Consumption Forecast (2022-2028)
-
8.5 Japan Intravenous (IV) Ibuprofen Consumption Forecast (2022-2028)
-
8.6 India Intravenous (IV) Ibuprofen Consumption Forecast (2022-2028)
-
8.7 South Korea Intravenous (IV) Ibuprofen Consumption Forecast (2022-2028)
9 Global Intravenous (IV) Ibuprofen Market Outlook by Types and Applications to 2022
-
9.1 Global Intravenous (IV) Ibuprofen Consumption and Growth Rate by Type (2017-2022)
-
9.1.1 Global 100 mg Dose Consumption and Growth Rate (2017-2022)
-
9.1.2 Global 200 mg Dose Consumption and Growth Rate (2017-2022)
-
9.1.3 Global 400 mg Dose Consumption and Growth Rate (2017-2022)
-
9.1.4 Global 800 mg Dose Consumption and Growth Rate (2017-2022)
-
9.2 Global Intravenous (IV) Ibuprofen Consumption and Growth Rate by Application (2017-2022)
-
9.2.1 Global Pain Consumption and Growth Rate (2017-2022)
-
9.2.2 Global Fever Consumption and Growth Rate (2017-2022)
-
9.2.3 Global Inflammation Consumption and Growth Rate (2017-2022)
10 Global Intravenous (IV) Ibuprofen Market Outlook by Types and Applications to 2028
-
10.1 Global Intravenous (IV) Ibuprofen Consumption Forecast and Growth Rate by Type (2022-2028)
-
10.1.1 Global 100 mg Dose Consumption Forecast and Growth Rate (2022-2028)
-
10.1.2 Global 200 mg Dose Consumption Forecast and Growth Rate (2022-2028)
-
10.1.3 Global 400 mg Dose Consumption Forecast and Growth Rate (2022-2028)
-
10.1.4 Global 800 mg Dose Consumption Forecast and Growth Rate (2022-2028)
-
10.2 Global Intravenous (IV) Ibuprofen Consumption Forecast and Growth Rate by Application (2022-2028)
-
10.2.1 Global Pain Consumption Forecast and Growth Rate (2022-2028)
-
10.2.2 Global Fever Consumption Forecast and Growth Rate (2022-2028)
-
10.2.3 Global Inflammation Consumption Forecast and Growth Rate (2022-2028)
11 Global Intravenous (IV) Ibuprofen Import and Export Analysis (Top 5 Countries)
-
11.1 Global Intravenous (IV) Ibuprofen Import by Region (Top 5 Countries) (2017-2028)
-
11.2 Global Intravenous (IV) Ibuprofen Export by Region (Top 5 Countries) (2017-2028)
12 Coronavirus Disease (COVID-19) Impact
-
12.1 Industry Impact Analysis
-
12.2 Intravenous (IV) Ibuprofen Market Outlook to 2028 - COVID-19 Affected Forecasts
13 Competition Matrix
-
13.1 Target Markets
-
13.2 Comprehensive Analysis of Products in Competitive Markets
14 Global Intravenous (IV) Ibuprofen Market Competitive Analysis
-
14.1 Germin MED
-
14.1.1 Germin MED Company Details
-
14.1.2 Germin MED Intravenous (IV) Ibuprofen Sales, Price, Value and Gross Profit (2017-2022)
-
14.1.3 Germin MED Intravenous (IV) Ibuprofen Product and Service
-
14.2 Laboratorios Valmorca
-
14.2.1 Laboratorios Valmorca Company Details
-
14.2.2 Laboratorios Valmorca Intravenous (IV) Ibuprofen Sales, Price, Value and Gross Profit (2017-2022)
-
14.2.3 Laboratorios Valmorca Intravenous (IV) Ibuprofen Product and Service
-
14.3 Grifols
-
14.3.1 Grifols Company Details
-
14.3.2 Grifols Intravenous (IV) Ibuprofen Sales, Price, Value and Gross Profit (2017-2022)
-
14.3.3 Grifols Intravenous (IV) Ibuprofen Product and Service
-
14.4 Al Nabeel International
-
14.4.1 Al Nabeel International Company Details
-
14.4.2 Al Nabeel International Intravenous (IV) Ibuprofen Sales, Price, Value and Gross Profit (2017-2022)
-
14.4.3 Al Nabeel International Intravenous (IV) Ibuprofen Product and Service
-
14.5 Gloria Pharmaceuticals
-
14.5.1 Gloria Pharmaceuticals Company Details
-
14.5.2 Gloria Pharmaceuticals Intravenous (IV) Ibuprofen Sales, Price, Value and Gross Profit (2017-2022)
-
14.5.3 Gloria Pharmaceuticals Intravenous (IV) Ibuprofen Product and Service
-
14.6 Cumberland Pharmaceuticals
-
14.6.1 Cumberland Pharmaceuticals Company Details
-
14.6.2 Cumberland Pharmaceuticals Intravenous (IV) Ibuprofen Sales, Price, Value and Gross Profit (2017-2022)
-
14.6.3 Cumberland Pharmaceuticals Intravenous (IV) Ibuprofen Product and Service
-
14.7 Alveda Pharmaceuticals
-
14.7.1 Alveda Pharmaceuticals Company Details
-
14.7.2 Alveda Pharmaceuticals Intravenous (IV) Ibuprofen Sales, Price, Value and Gross Profit (2017-2022)
-
14.7.3 Alveda Pharmaceuticals Intravenous (IV) Ibuprofen Product and Service
-
14.8 Sandor Medicaids
-
14.8.1 Sandor Medicaids Company Details
-
14.8.2 Sandor Medicaids Intravenous (IV) Ibuprofen Sales, Price, Value and Gross Profit (2017-2022)
-
14.8.3 Sandor Medicaids Intravenous (IV) Ibuprofen Product and Service
-
14.9 CSL Limited
-
14.9.1 CSL Limited Company Details
-
14.9.2 CSL Limited Intravenous (IV) Ibuprofen Sales, Price, Value and Gross Profit (2017-2022)
-
14.9.3 CSL Limited Intravenous (IV) Ibuprofen Product and Service
-
14.10 PT Soho Industri Pharmasi
-
14.10.1 PT Soho Industri Pharmasi Company Details
-
14.10.2 PT Soho Industri Pharmasi Intravenous (IV) Ibuprofen Sales, Price, Value and Gross Profit (2017-2022)
-
14.10.3 PT Soho Industri Pharmasi Intravenous (IV) Ibuprofen Product and Service
15 Appendix
TABLE OF CHARTS
-
Table Definition of Intravenous (IV) Ibuprofen
-
Figure Intravenous (IV) Ibuprofen Picture
-
Table Global Intravenous (IV) Ibuprofen Market Size and Forecast 2022 - 2028 (USD million)
-
Figure Global Intravenous (IV) Ibuprofen Market Size and Forecast 2022 - 2028 (USD million)
-
Figure Global Intravenous (IV) Ibuprofen Market: Year-over-year Growth 2022 - 2028 (%)
-
Table Parent Market Analysis
-
Figure Parent Market Price
-
Table Related/Ancillary Market Outlook Analysis
-
Table Supplier Power Analysis
-
Table Buyer Power Analysis
-
Table Substitution Threat Analysis
-
Table Threat of New Entrants Analysis
-
Table Competitive Rivalry Analysis
-
Figure Global Intravenous (IV) Ibuprofen Consumption by Country (2017-2022)
-
Figure United States Intravenous (IV) Ibuprofen Consumption and Growth Rate (2017-2022)
-
Table Europe Intravenous (IV) Ibuprofen Consumption and Growth Rate (2017-2022)
-
Figure China Intravenous (IV) Ibuprofen Consumption and Growth Rate (2017-2022)
-
Figure Japan Intravenous (IV) Ibuprofen Consumption and Growth Rate (2017-2022)
-
Figure India Intravenous (IV) Ibuprofen Consumption and Growth Rate (2017-2022)
-
Figure South Korea Intravenous (IV) Ibuprofen Consumption and Growth Rate (2017-2022)
-
Figure Global Intravenous (IV) Ibuprofen Consumption Forecast by Country (2022-2028)
-
Figure United States Intravenous (IV) Ibuprofen Consumption Forecast and Growth Rate (2022-2028)
-
Table Europe Intravenous (IV) Ibuprofen Consumption Forecast and Growth Rate (2022-2028)
-
Figure China Intravenous (IV) Ibuprofen Consumption Forecast and Growth Rate (2022-2028)
-
Figure Japan Intravenous (IV) Ibuprofen Consumption Forecast and Growth Rate (2022-2028)
-
Figure India Intravenous (IV) Ibuprofen Consumption Forecast and Growth Rate (2022-2028)
-
Figure South Korea Intravenous (IV) Ibuprofen Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global 100 mg Dose Consumption and Growth Rate (2017-2022)
-
Figure Global 200 mg Dose Consumption and Growth Rate (2017-2022)
-
Figure Global 400 mg Dose Consumption and Growth Rate (2017-2022)
-
Figure Global 800 mg Dose Consumption and Growth Rate (2017-2022)
-
Figure Global Pain Consumption and Growth Rate (2017-2022)
-
Figure Global Fever Consumption and Growth Rate (2017-2022)
-
Figure Global Inflammation Consumption and Growth Rate (2017-2022)
-
Figure Global 100 mg Dose Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global 200 mg Dose Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global 400 mg Dose Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global 800 mg Dose Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Pain Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Fever Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Inflammation Consumption Forecast and Growth Rate (2022-2028)
-
Table Global Intravenous (IV) Ibuprofen Import by Region (Top 5 Countries) (2017-2028)
-
Table Global Intravenous (IV) Ibuprofen Export by Region (Top 5 Countries) (2017-2028)
-
Table Germin MED (Foundation Year, Company Profile and etc.)
-
Table Germin MED Intravenous (IV) Ibuprofen Sales, Price, Value and Gross Profit (2017-2022)
-
Table Germin MED Intravenous (IV) Ibuprofen Product and Service
-
Table Laboratorios Valmorca (Foundation Year, Company Profile and etc.)
-
Table Laboratorios Valmorca Intravenous (IV) Ibuprofen Sales, Price, Value and Gross Profit (2017-2022)
-
Table Laboratorios Valmorca Intravenous (IV) Ibuprofen Product and Service
-
Table Grifols (Foundation Year, Company Profile and etc.)
-
Table Grifols Intravenous (IV) Ibuprofen Sales, Price, Value and Gross Profit (2017-2022)
-
Table Grifols Intravenous (IV) Ibuprofen Product and Service
-
Table Al Nabeel International (Foundation Year, Company Profile and etc.)
-
Table Al Nabeel International Intravenous (IV) Ibuprofen Sales, Price, Value and Gross Profit (2017-2022)
-
Table Al Nabeel International Intravenous (IV) Ibuprofen Product and Service
-
Table Gloria Pharmaceuticals (Foundation Year, Company Profile and etc.)
-
Table Gloria Pharmaceuticals Intravenous (IV) Ibuprofen Sales, Price, Value and Gross Profit (2017-2022)
-
Table Gloria Pharmaceuticals Intravenous (IV) Ibuprofen Product and Service
-
Table Cumberland Pharmaceuticals (Foundation Year, Company Profile and etc.)
-
Table Cumberland Pharmaceuticals Intravenous (IV) Ibuprofen Sales, Price, Value and Gross Profit (2017-2022)
-
Table Cumberland Pharmaceuticals Intravenous (IV) Ibuprofen Product and Service
-
Table Alveda Pharmaceuticals (Foundation Year, Company Profile and etc.)
-
Table Alveda Pharmaceuticals Intravenous (IV) Ibuprofen Sales, Price, Value and Gross Profit (2017-2022)
-
Table Alveda Pharmaceuticals Intravenous (IV) Ibuprofen Product and Service
-
Table Sandor Medicaids (Foundation Year, Company Profile and etc.)
-
Table Sandor Medicaids Intravenous (IV) Ibuprofen Sales, Price, Value and Gross Profit (2017-2022)
-
Table Sandor Medicaids Intravenous (IV) Ibuprofen Product and Service
-
Table CSL Limited (Foundation Year, Company Profile and etc.)
-
Table CSL Limited Intravenous (IV) Ibuprofen Sales, Price, Value and Gross Profit (2017-2022)
-
Table CSL Limited Intravenous (IV) Ibuprofen Product and Service
-
Table PT Soho Industri Pharmasi (Foundation Year, Company Profile and etc.)
-
Table PT Soho Industri Pharmasi Intravenous (IV) Ibuprofen Sales, Price, Value and Gross Profit (2017-2022)
-
Table PT Soho Industri Pharmasi Intravenous (IV) Ibuprofen Product and Service
-
